Skip to main content
. 2018 Feb 7;35(3):32. doi: 10.1007/s12032-018-1087-6

Table 2.

Summary of treatment results

Best response Number of patients (%)
CR 4 (10.5%)
PR 15 (39.5%)
SD 2 (3.5%)
PD 7 (18.4%)
Not evaluable 10 (26%)
 Death prior to imaging 8
 Lost to follow-up 2